Neonatal and Paediatric Pharmacists Conference, Bristol, UK, November 2018 P004 An evaluation of the management of thrombosis in neonates and infants using dalteparin Free Sian Gaze1, Falak Latif2, Kim Wolff2 1Evelina London Children’s Hospital 2King’s College London Abstract Aim To assess the safety and efficacy of the current dalteparin dosing recommendations in achieving therapeutic anti-Xa levels, when used for the treatment of thrombosis in neonates and infants.
